Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.
News > Health News
Audio By Carbonatix
5:30 AM on Tuesday, January 27
The Associated Press
SAN DIEGO--(BUSINESS WIRE)--Jan 27, 2026--
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and fiscal year 2025 financial results after market close on Thursday, February 12, 2026. Management will hold a conference call to review the company's fourth quarter and fiscal year 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be archived there for future reference.
To listen to the conference call, please dial (888) 414-4585 (US/Canada) or (646) 960-0331 (International) and use the confirmation ID "9430114" approximately five minutes prior to the start time.
About DexCom, Inc.
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Category: IR
View source version on businesswire.com:https://www.businesswire.com/news/home/20260127817991/en/
CONTACT: DexCom, Inc.:
Sean Christensen
Vice President – Finance and Investor Relations
(858) 200-0200
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: DIABETES HEALTH TECHNOLOGY HEALTH MEDICAL DEVICES
SOURCE: DexCom, Inc.
Copyright Business Wire 2026.
PUB: 01/27/2026 08:30 AM/DISC: 01/27/2026 08:33 AM
http://www.businesswire.com/news/home/20260127817991/en
